Year |
Citation |
Score |
2023 |
Aronowitz SV, Carroll JJ, Hansen H, Jauffret-Roustide M, Parker CM, Suhail-Sindhu S, Albizu-Garcia C, Alegria M, Arrendondo J, Baldacchino A, Bluthental R, Bourgois P, Burraway J, Chen JS, Ekhtiari H, ... ... Knight K, et al. Substance use policy and practice in the COVID-19 pandemic: Learning from early pandemic responses through internationally comparative field data. Global Public Health. 1-16. PMID 36692903 DOI: 10.1080/17441692.2022.2129720 |
0.607 |
|
2020 |
Behar E, Bagnulo R, Knight K, Santos GM, Coffin PO. "Chasing the pain relief, not the high": Experiences managing pain after opioid reductions among patients with HIV and a history of substance use. Plos One. 15: e0230408. PMID 32210442 DOI: 10.1371/Journal.Pone.0230408 |
0.322 |
|
2019 |
Satterwhite S, Knight KR, Miaskowski C, Chang JS, Ceasar R, Zamora K, Kushel M. Sources and Impact of Time Pressure on Opioid Management in the Safety-Net. Journal of the American Board of Family Medicine : Jabfm. 32: 375-382. PMID 31068401 DOI: 10.3122/Jabfm.2019.03.180306 |
0.303 |
|
2017 |
Knight KR. Women on the Edge: Opioids, Benzodiazepines, and the Social Anxieties Surrounding Women's Reproduction in the U.S. "Opioid Epidemic". Contemporary Drug Problems. 44: 301-320. PMID 31537950 DOI: 10.1177/0091450917740359 |
0.36 |
|
2017 |
Knight KR, Kushel M, Chang JS, Zamora K, Ceasar R, Hurstak E, Miaskowski C. Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use. Social Science & Medicine (1982). 186: 87-95. PMID 28599142 DOI: 10.1016/J.Socscimed.2017.05.043 |
0.352 |
|
2017 |
Hurstak EE, Kushel M, Chang J, Ceasar R, Zamora K, Miaskowski C, Knight K. The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics. Substance Abuse. 1-9. PMID 28394752 DOI: 10.1080/08897077.2017.1296524 |
0.314 |
|
2016 |
Chang JS, Kushel M, Miaskowski C, Ceasar R, Zamora K, Hurstak E, Knight KR. Provider Experiences With the Identification, Management, and Treatment of Co-occurring Chronic Noncancer Pain and Substance Use in the Safety Net. Substance Use & Misuse. 1-5. PMID 27754719 DOI: 10.1080/10826084.2016.1223138 |
0.306 |
|
2015 |
Ceasar R, Chang J, Zamora K, Hurstak E, Kushel M, Miaskowski C, Knight K. Primary Care Providers' Experiences with Urine Toxicology Tests to Manage Prescription Opioid Misuse and Substance Use Among Chronic Non-Cancer Pain Patients in Safety Net Healthcare Settings. Substance Abuse. 0. PMID 26682471 DOI: 10.1080/08897077.2015.1132293 |
0.323 |
|
2015 |
Mizuno Y, Purcell DW, Knowlton AR, Wilkinson JD, Gourevitch MN, Knight KR. Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users. Aids and Behavior. 19: 684-93. PMID 25249392 DOI: 10.1007/S10461-014-0890-0 |
0.368 |
|
2015 |
Knight KR. addicted.pregnant.poor Materials. 3: 163. DOI: 10.1215/9780822375180 |
0.328 |
|
2014 |
Riley ED, Cohen J, Knight KR, Decker A, Marson K, Shumway M. Recent violence in a community-based sample of homeless and unstably housed women with high levels of psychiatric comorbidity. American Journal of Public Health. 104: 1657-63. PMID 25033127 DOI: 10.2105/Ajph.2014.301958 |
0.304 |
|
2014 |
Knight KR, Das M, DeMicco E, Raiford JL, Matheson T, Shook A, Antunez E, Santos GM, Dadasovich R, Dilley JW, Colfax GN, Herbst JH. A roadmap for adapting an evidence-based HIV prevention intervention: personal cognitive counseling (PCC) for episodic substance-using men who have sex with men. Prevention Science : the Official Journal of the Society For Prevention Research. 15: 364-75. PMID 23412947 DOI: 10.1007/S11121-013-0364-Z |
0.381 |
|
2012 |
Mackenzie S, Pearson C, Frye V, Gómez CA, Latka MH, Purcell DW, Knowlton AR, Metsch LR, Tobin KE, Valverde EE, Knight KR. Agents of change: peer mentorship as HIV prevention among HIV-positive injection drug users. Substance Use & Misuse. 47: 522-34. PMID 22428820 DOI: 10.3109/10826084.2012.644122 |
0.38 |
|
2010 |
Rose CD, Courtenay-Quirk C, Knight K, Shade SB, Vittinghoff E, Gomez C, Lum PJ, Bacon O, Colfax G. HIV intervention for providers study: A randomized controlled trial of a clinician-delivered HIV risk-reduction intervention for HIV-positive people Journal of Acquired Immune Deficiency Syndromes. 55: 572-581. PMID 20827218 DOI: 10.1097/Qai.0B013E3181Ee4C62 |
0.368 |
|
2009 |
Mizuno Y, Purcell DW, Zhang J, Knowlton AR, De Varona M, Arnsten JH, Knight KR. Predictors of current housing status among HIV-seropositive injection drug users (IDUs): results from a 1-year study. Aids and Behavior. 13: 165-72. PMID 18247113 DOI: 10.1007/S10461-008-9364-6 |
0.403 |
|
2008 |
Latkin CA, Buchanan AS, Metsch LR, Knight K, Latka MH, Mizuno Y, Knowlton AR. Predictors of sharing injection equipment by HIV-seropositive injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 49: 447-50. PMID 19186356 DOI: 10.1097/Qai.0B013E31818A6546 |
0.41 |
|
2007 |
Knight KR, Shade SB, Purcell DW, Rose CD, Metsch LR, Latka MH, Latkin CA, Gómez CA. Sexual transmission risk behavior reported among behaviorally bisexual HIV-positive injection drug-using men. Journal of Acquired Immune Deficiency Syndromes (1999). 46: S80-7. PMID 18089988 DOI: 10.1097/Qai.0B013E3181576828 |
0.376 |
|
2007 |
Arnsten JH, Li X, Mizuno Y, Knowlton AR, Gourevitch MN, Handley K, Knight KR, Metsch LR. Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 46: S64-71. PMID 18089986 DOI: 10.1097/Qai.0B013E31815767D6 |
0.317 |
|
2007 |
Purcell DW, Latka MH, Metsch LR, Latkin CA, Gómez CA, Mizuno Y, Arnsten JH, Wilkinson JD, Knight KR, Knowlton AR, Santibanez S, Tobin KE, Rose CD, Valverde EE, Gourevitch MN, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 46: S35-47. PMID 18089983 DOI: 10.1097/Qai.0B013E31815767C4 |
0.375 |
|
2007 |
Frye V, Latka MH, Wu Y, Valverde EE, Knowlton AR, Knight KR, Arnsten JH, O'Leary A. Intimate partner violence perpetration against main female partners among HIV-positive male injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 46: S101-9. PMID 18089979 DOI: 10.1097/Qai.0B013E31815767E6 |
0.397 |
|
2006 |
Purcell DW, Mizuno Y, Metsch LR, Garfein R, Tobin K, Knight K, Latka MH. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 83: 656-68. PMID 16736116 DOI: 10.1007/S11524-006-9066-1 |
0.374 |
|
2006 |
Missildine W, Parsons JT, Knight K. Split ends: Masculinity, sexuality and emotional intimacy among HIV-positive heterosexual men Men and Masculinities. 8: 309-320. DOI: 10.1177/1097184X05282079 |
0.313 |
|
2005 |
Knight KR, Purcell D, Dawson-Rose C, Halkitis PN, Gomez CA. Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 17: 76-88. PMID 15843119 DOI: 10.1521/Aeap.17.2.76.58692 |
0.403 |
|
2005 |
Comfort M, Grinstead O, McCartney K, Bourgois P, Knight K. "You cannot do nothing in this damn place": sex and intimacy among couples with an incarcerated male partner. Journal of Sex Research. 42: 3-12. PMID 15795799 DOI: 10.1080/00224490509552251 |
0.353 |
|
2003 |
Mizuno Y, Purcell D, Borkowski TM, Knight K. The life priorities of HIV-seropositive injection drug users: findings from a community-based sample. Aids and Behavior. 7: 395-403. PMID 14707536 DOI: 10.1023/B:Aibe.0000004731.94734.77 |
0.367 |
|
2001 |
Downing M, Knight K, Reiss TH, Vernon K, Mulia N, Ferreboeuf M, Carroll A, Vu C. Drug users talk about HIV testing: motivating and deterring factors. Aids Care-Psychological and Socio-Medical Aspects of Aids\/Hiv. 13: 561-577. PMID 11571004 DOI: 10.1080/09540120120063205 |
0.381 |
|
2001 |
Vernon KA, Mulia N, Downing M, Knight K, Reiss T. “I don't know when it might pop up”: Understanding repeat HIV testing and perceptions of HIV among drug users Journal of Substance Abuse. 13: 215-227. PMID 11547621 DOI: 10.1016/S0899-3289(01)00067-0 |
0.373 |
|
1998 |
Van Der Straten A, Vernon KA, Knight KR, Gómez CA, Padian NS. Managing HIV among serodiscordant heterosexual couples: Serostatus, stigma and sex Aids Care - Psychological and Socio-Medical Aspects of Aids/Hiv. 10: 533-548. PMID 9828951 DOI: 10.1080/09540129848406 |
0.37 |
|
1996 |
Rosenbaum M, Washbum A, Knight K, Kelley MS, Irwin J. Treatment as harm reduction, defunding as harm maximization: the case of methadone maintenance. Journal of Psychoactive Drugs. 28: 241-249. PMID 8895109 DOI: 10.1080/02791072.1996.10472485 |
0.376 |
|
1996 |
Knight KR, Rosenbaum M, Irwin J, Kelley MS, Wenger L, Washburn A. Involuntary versus voluntary detoxification from methadone maintenance treatment: The importance of choice Addiction Research and Theory. 3: 351-362. DOI: 10.3109/16066359609005248 |
0.307 |
|
1996 |
Knight KR, Rosenbaum M, Kelley MS, Irwin J, Washburn A, Wenger L. Defunding the poor: The impact of lost access to subsidized methadone maintenance treatment on women injection drug users Journal of Drug Issues. 26: 923-942. DOI: 10.1177/002204269602600411 |
0.317 |
|
1996 |
Kelley MS, Rosenbaum M, Knight K, Irwin J, Washburn A. Violence: A Barrier To Methadone Maintenance Treatment For Women Injection Drug Users International Journal of Sociology and Social Policy. 16: 156-177. DOI: 10.1108/Eb013260 |
0.331 |
|
Show low-probability matches. |